Stockscreener 앱 받기
23.50
0.64%
0.15
시장 영업 전:
23.90
0.40
+1.70%
전일 마감가:
$23.35
열려 있는:
$23.21
하루 거래량:
486.47K
Relative Volume:
0.80
시가총액:
$1.16B
수익:
$723.55M
순이익/손실:
$157.72M
주가수익비율:
7.8333
EPS:
3
순현금흐름:
$170.15M
1주 성능:
-3.77%
1개월 성능:
-16.93%
6개월 성능:
-53.76%
1년 성능:
-41.26%
1일 변동 폭
$22.84
$23.59
1주일 범위
$22.64
$24.92
52주 변동 폭
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.50 | 1.16B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Mesirow Institutional Investment Management Inc. Has $14.12 Million Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com
U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com
JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat
Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa
Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Australia
Portolan Capital Management LLC Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance
Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World
Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com
Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Renaissance Group LLC Has $3.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowShould You Sell? - MarketBeat
Needham & Company LLC Reiterates Hold Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Dynamic Technology Lab Private Ltd Acquires 14,468 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Glucagon Market Set to Witness Significant Growth by 2032 | Eli - openPR.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Increased by Vanguard Group Inc. - Defense World
Trexquant Investment LP Acquires 16,248 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar at Needham Conference: Strategic Growth Amidst Challenges By Investing.com - Investing.com Canada
Amphastar stock hits 52-week low at $25.72 amid market challenges - Investing.com Australia
Amphastar stock hits 52-week low at $25.72 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stock - MarketBeat
KLP Kapitalforvaltning AS Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 3.1%Should You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by American Century Companies Inc. - MarketBeat
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021 - ACCESS Newswire
We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Stay On Top Of Its Debt - simplywall.st
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 - ACCESS Newswire
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - ACCESS Newswire
Amphastar Leadership Team Set for Major Investor Presentation at Needham Conference - Stock Titan
Amphastar Pharmaceuticals director sells $14,190 in stock - Investing.com India
Amphastar Pharmaceuticals director sells $14,190 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.69%
자본화:
|
볼륨(24시간):